Imugene (IMU) was Forrest Capital's “worst” performing biotech shell….was pretty much break even for ages but rose 60-70% this morning on a good test result before being sold back a bit. Anyways, I have bought some more SBN this week.
SBN Price at posting:
1.0¢ Sentiment: Buy Disclosure: Held